Valuation : Evotec SE

Market Cap 60Cr 69Cr 56Cr 51Cr 96Cr 6.6TCr 96Cr 661.99Cr 258.28Cr 3.33TCr 259.29Cr 253.65Cr 11TCr P/E 2026 *
-2.85x
P/E 2027 * -7.78x
Enterprise Value 74Cr 86Cr 69Cr 63Cr 118.99Cr 8.18TCr 119.36Cr 820.89Cr 320.28Cr 4.13TCr 321.53Cr 314.54Cr 14TCr EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.05x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-1.06%
1 week-0.24%
Current month-1.82%
1 month-4.45%
3 months-34.48%
6 months-43.06%
Current year-38.57%
1 week 3.24
Extreme 3.24
3.41
1 month 3.24
Extreme 3.24
3.88
Current year 3.18
Extreme 3.176
6.73
1 year 3.18
Extreme 3.176
7.3
3 years 3.18
Extreme 3.176
23.44
5 years 3.18
Extreme 3.176
45.83
10 years 3.18
Extreme 3.176
45.83
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 59 10/06/2024
Date Insider Type Main position Quantity % Market Cap.
20/05/26 Fiscal year

Chief Technology Officer

12,462 0.0070%
04/05/26 Buy 15,510 0.0087%
04/05/26 Buy

Head of Human Resources

15,228 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-0.24%-44.18%-83.83% 69Cr
-0.78%-1.42%+2.49%+22.78% 5.05TCr
-6.00%-0.75%+442.41%+544.39% 4.46TCr
-0.24%+0.74%+38.69%+18.02% 4.31TCr
-1.55%-2.07%+23.08%+81.47% 4.17TCr
-0.31%-0.83%+16.15%+51.42% 3.32TCr
-1.79%-3.24%+27.00%+129.56% 1.68TCr
-0.58%-2.12% - - 1.63TCr
-0.88%-0.66%+11.60%+27.75% 1.46TCr
-1.66%-1.25%+78.59%+46.66% 1.39TCr
Average -1.48%-0.98%+66.20%+93.14% 2.75TCr
Weighted average by Cap. -1.70%-1.06%+95.34%+133.05%

Financials

2026 *2027 *
Net sales 60Cr 70Cr 56Cr 51Cr 97Cr 6.65TCr 97Cr 667.07Cr 260.27Cr 3.36TCr 261.28Cr 255.6Cr 11TCr 72Cr 83Cr 67Cr 62Cr 115.96Cr 7.98TCr 116.33Cr 800.02Cr 312.14Cr 4.03TCr 313.36Cr 306.54Cr 13TCr
Net income -24Cr -27Cr -22Cr -20Cr -38Cr -2.62TCr -38Cr -262.34Cr -102.36Cr -1.32TCr -102.76Cr -100.52Cr -4.38TCr -6.04Cr -7.01Cr -5.66Cr -5.17Cr -9.73Cr -669.6Cr -9.77Cr -67Cr -26Cr -338.01Cr -26Cr -26Cr -1.12TCr
Net Debt 14Cr 17Cr 13Cr 12Cr 23Cr 1.58TCr 23Cr 158.9Cr 62Cr 799.79Cr 62Cr 61Cr 2.65TCr 16Cr 19Cr 15Cr 14Cr 26Cr 1.8TCr 26Cr 180.39Cr 70Cr 907.95Cr 71Cr 69Cr 3.01TCr
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
28/26/28 €3.348 -1.06% 4,21,031
27/26/27 €3.384 +0.89% 3,01,999
26/26/26 €3.354 +3.07% 9,30,144
25/26/25 €3.254 -0.61% 10,89,610
24/26/24 €3.274 -2.44% 5,99,723
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.348EUR
Average target price
4.586EUR
Spread / Average Target
+36.97%

Quarterly revenue - Rate of surprise